AzTrials
AzTrials

Trigger PointsNCT04394741

Effects of Dry Needling on Stiffness in Latent Trigger Points

A study testing Intervention-Dry Needling in people with Trigger Points, run by University of Castilla-La Mancha at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether application of Dry Needling (DN) is effective for reduced on Stiffness in Latent trigger point (LTrP) of upper trapezius. The secondary purposes are to determine the correlation on two elastography for stiffness measure (Shear-wave elastography and Strain… Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Trigger Points
What is being tested?
Intervention-Dry Needling
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
51 participants
Where
1 siteSpain
Study dates
1 Jun 2020to 31 Aug 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age between 18 and 30 years
  • The presence of LTrP in the middle third of the upper trapezius muscle on the dominant side
  • Being able to provide written informed consent
  • Being able to follow instructions and realize clinical tests

Who cannot join

  • Any pharmacological therapeutic
  • Any medical treatment or physical therapies at cervical region during the 6-month before this study - Any diagnosed health problem
  • Any history of head and upper extremity surgery or trauma
  • Any red flags to DN, (ie: metabolic diseases, pregnancy, kinesiophobia, Infection, cancer)
  • Absence of recurrent history of neck pain
  • No neck pain symptomatology the previous 6 months
  • Cervical disk herniation

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Performance and Sport Rehabilitation Laboratory

    Toledo, 45071

Other trials in Spain

About this study

Official title: Effects of Dry Needling on Stiffness in Latent Myofascial Trigger Points: a Randomized Controlled Trial

The purpose of this study is to determine whether application of Dry Needling (DN) is effective for reduced on Stiffness in Latent trigger point (LTrP) of upper trapezius. The secondary purposes are to determine the correlation on two elastography for stiffness measure (Shear-wave elastography and Strain elastography). Randomized controlled trial, in parallel with cross-control design. Two groups with LTrP in upper trapezius, and will be randomly selected to DN group or Sham-Dn group.

Conditions
Trigger Points
Being tested
Intervention-Dry Needling, Control-Dry Needling
Keywords
Pain, Latent trigger point, Stiffness, Dry Needling
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intervention-Dry NeedlingDevice

    Deep Dry Needling into the site of the latent Trigger Point of the upper trapezius muscle.

    1 session in upper trapezius muscle moving the needle up and down ten times.

  • Control-Dry NeedlingDevice

    Sham Dry Needling into the site of the latent Trigger Point of the upper trapezius muscle with non-penetrating needles

    1 session in upper trapezius muscle moving the needle up and down ten times.

Study groups in NCT04394741
Study groupRoleWhat they receive
Deep Dry NeedlingExperimentalIntervention-Dry Needling: Deep Dry Needing into the latent trigger point of the upper trapezius muscle
Receives: Device: Intervention-Dry Needling
Sham Dry NeedlingSham comparatorControl-Dry Needling: Sham Dry Needling into the latent trigger point of the upper trapezius muscle
Receives: Device: Intervention-Dry Needling; Device: Control-Dry Needling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change on Stiffness (Shear wave elastography and Strain Elastography)

    Shear-wave Elastography (SWE) as assessed using an Logiq S8 US system (GE Healthcare).

    The stiffness was determined with measuring velocity of shear waves in trapezius muscle on SWE exam.

    Strain elastography (SEL) as assessed using an Logiq S8 US system (GE Healthcare).

    The stiffness was determined by applying light repetitive compression with the hand-held transducer

    Measured: Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment

Secondary outcomes (3)
  1. Change in Pain Pressure Threshold (PPT)

    Pressure-Pain Threshold as assessed by an manual mechanical algometer. PPT is the minimal amount of pressure that produces pain and is used to assess abnormalities in nociceptive processing or hyperalgesia.

    Measured: Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment

  2. Change in Thickness of muscle

    The muscle was scanned in the longitudinal and axial planes, taking care to avoid anisotropy. B-Mode gray scale was employed to measure muscle thickness

    Measured: Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment

  3. Change in Post-needling soreness

    The procedure performed was the subject had to characterize the level of pain using a visual analog scale (VAS), ranging from 0mm (no pain) to 10mm (worst imaginable pain)

    Measured: Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2020
  2. Study start1 Jun 2020
  3. Primary completion31 Jul 2020
  4. Study completion31 Aug 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
51 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04394741
Sponsor's protocol ID
DNStiffness
Status last verified
Sep 2020
First submitted
10 May 2020
Last updated
5 Oct 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ruiz-Saez M, Fernandez-de-las-Penas C, Blanco CR, Martinez-Segura R, Garcia-Leon R. Changes in pressure pain sensitivity in latent myofascial trigger points in the upper trapezius muscle after a cervical spine manipulation in pain-free subjects. J Manipulative Physiol Ther. 2007 Oct;30(8):578-83. doi: 10.1016/j.jmpt.2007.07.014.

    PubMed 17996549
  • Grabowski PJ, Slane LC, Thelen DG, Obermire T, Lee KS. Evidence of Generalized Muscle Stiffness in the Presence of Latent Trigger Points Within Infraspinatus. Arch Phys Med Rehabil. 2018 Nov;99(11):2257-2262. doi: 10.1016/j.apmr.2018.03.024. Epub 2018 Apr 28.

    PubMed 29709524
  • Maher RM, Hayes DM, Shinohara M. Quantification of dry needling and posture effects on myofascial trigger points using ultrasound shear-wave elastography. Arch Phys Med Rehabil. 2013 Nov;94(11):2146-50. doi: 10.1016/j.apmr.2013.04.021. Epub 2013 May 14.

    PubMed 23684553
  • Luan S, Zhu ZM, Ruan JL, Lin CN, Ke SJ, Xin WJ, Liu CC, Wu SL, Ma C. Randomized Trial on Comparison of the Efficacy of Extracorporeal Shock Wave Therapy and Dry Needling in Myofascial Trigger Points. Am J Phys Med Rehabil. 2019 Aug;98(8):677-684. doi: 10.1097/PHM.0000000000001173.

    PubMed 31318748
  • Sanchez-Infante J, Bravo-Sanchez A, Jimenez F, Abian-Vicen J. Effects of Dry Needling on Muscle Stiffness in Latent Myofascial Trigger Points: A Randomized Controlled Trial. J Pain. 2021 Jul;22(7):817-825. doi: 10.1016/j.jpain.2021.02.004. Epub 2021 Feb 23.

    PubMed 33636373

Questions about this trial

What is this clinical trial studying?

A study testing Intervention-Dry Needling in people with Trigger Points, run by University of Castilla-La Mancha at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change on Stiffness (Shear wave elastography and Strain Elastography) (time frame: Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04394741, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in